Editing
Infertility: Management
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===== Options (3): ===== # '''hCG''' # '''FSH''' # '''GnRH''' #* ====== hCG ====== *'''<span style="color:#ff0000">Mechanism of Action: stimulates testosterone production from Leydig cells by mimicking LH</span>''' **'''hCG has the same structure as the beta unit for LH''' *'''When used in conjunction with exogenous testosterone administration, may reverse azoospermia and maintain elevated intratesticular testosterone levels''' **'''By directly stimulating Leydig cells, intratesticular testosterone increases regardless of the extent of negative feedback on the HPG axis, improving spermatogenesis.''' **Greater effect seen in males with initial testes length >4cm **'''Effect improved with addition of FSH''' or hMG ***Most experts treat with hCG alone for 3 to 6 months after which spermatogenesis induction occurs in some cases. ***For patients without adequate spermatogenesis induction, treatment proceeds with the addition of FSH *'''Indications''' **'''FDA approved for treatment of pituitary hypogonadism in males''' **Classically used to treat hypogonadotropic hypogonadism, such as Kallmann syndrome. ====== FSH ====== *When given alone or in combination with testosterone, has proven unsuccessful at inducing spermatogenesis or maintaining spermatogenesis in those previously induced with hCG/FSH, confirming the need for maintenance of elevated intratesticular testosterone. * '''Indications''' ** '''<span style="color:#ff0000">Infertility associated with hypogonadotropic hypogonadism</span>[https://pubmed.ncbi.nlm.nih.gov/33295257/ β ]''' ** '''<span style="color:#ff0000">Not FDA-approved for use in males[https://pubmed.ncbi.nlm.nih.gov/33295257/ β ]</span>''' * '''hCG/FSH not used frequently due to cost''' **hCG is more expensive than clomiphene citrate and anastrozole, and requires multiple weekly subcutaneous injections. * Adverse events ** hCG is generally well tolerated but there are reports of gynecomastia in up to a third of the patients, which should be monitored. ***If gynecomastia does occur, anastrazole would be the first line treatment option. **'''Same theoretical risk of testosterone replacement exists''' ====== GnRH ====== * Pulsatile GnRH is not currently approved in the US or Europe[https://pubmed.ncbi.nlm.nih.gov/33295257/ Β§]
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information